6.77美元0.04(0.59%)
2023/03/29更新
績效 / 1月2.27%
3月2.17%
1年18.73%
晨星評等-
淨值走勢
持股明細 / 風險評估
- 1.美國82.91%
- 2.新興亞洲4.52%
- 3.日本2.79%
- 4.已開發亞洲1.24%
- 5.中東0.92%
- 1.健康護理92.26%
- 2.基本物料0.38%
- 3.周期性消費0.31%
- 1.Johnson & Johnson6.23%
- 2.UnitedHealth Group Inc6.00%
- 3.Eli Lilly and Co5.72%
- 4.Merck & Co Inc4.20%
- 5.Regeneron Pharmaceuticals Inc4.15%
- 1.美國82.91%
- 2.新興亞洲4.52%
- 3.日本2.79%
- 4.已開發亞洲1.24%
- 5.中東0.92%
- 1.Johnson & Johnson6.23%
- 2.UnitedHealth Group Inc6.00%
- 3.Eli Lilly and Co5.72%
- 4.Merck & Co Inc4.20%
- 5.Regeneron Pharmaceuticals Inc4.15%
- 1.健康護理92.26%
- 2.基本物料0.38%
- 3.周期性消費0.31%